Mohammed Milhem, 319-356-2324
Participants in this study have been diagnosed with a type of bone cancer called chondrosarcoma that has spread to other parts of the body or is not able to be removed with surgery. In this study, all subjects will receive the drug pazopanib. This research study is being performed at about 5 clinics across the US. Approximately 47 subjects will take part in this study.
Please help us improve your experience on our website by completing a brief survey
Yes, I'll give feedback No, Thanks
Your browser does not support iframes.